The research of the GHP could be structured in several broader categories exploring:
Overview of the different research projects of the GHP:
The interim report “Supporting Health 2020 – Governance for Health in the 21st Century” commissioned by the WHO Regional Office for Europe provides policy makers with examples from around the world of how whole of government and whole of society approaches have been implemented. Furthermore, a set of process tools to manage the complex policy process and best practice examples with model character covering a wide variety of different contexts and countries have been provided in the study. These examples were related to the priorities areas set by the Health 2020 policy framework and the study particularly aims at contributing to the Health 2020 strategic policy objective of “improving leadership and participatory governance for health”. In this context, health is more and more understood as a product of complex and dynamic relations generated by numerous determinants at different levels of governance. Determinants may be social, but increasingly also political and commercial. Governments need to take into account the impact of this wide variety of health determinants as well as the overall societal conditions including economic constraints, demographic changes and unhealthy lifestyles in many European countries. A country’s health system alone has neither the capacities nor the adequate steering instruments to solve such multi-dimensional problems in a substantial and comprehensive way. As a consequence, the study seeks to show how shared governance already takes place in many occasions and how values and accountability can be uphold across different sectors and a great variety of stakeholders. Criteria for modern policy-making are established and shown how the bringing together of a variety of different stakeholders may – if managed well – create synergies and be mutually supportive in democratic political systems.
This working paper was a lobbying document to inform and advocate for the European Commission to include global health in its next round of ERC Research Funding.
‘Europe is well placed to take a lead role in developing global health research and innovation. This paper explores the potential and makes recommendations for Europe’s role in research and innovation to improve global health. It highlights the need for coherence between Horizon 2020 and other key EU policies, including that on the EU’s role in global health, and the potential for global health research to play an instrumental role in achieving Europe 2020 goals of growth, innovation and social inclusion. Recommendations for research mechanisms and strategies to develop Europe’s role in and progress global health research and innovation include: special mechanisms to promote and support research that is cross-sectoral and interdisciplinary, involving both technological and social innovation; special mechanisms to ensure continued fair, equitable and needs-oriented collaboration with LMICs, including joint priority and agenda setting, management, exploitation of results; research that acknowledges the ‘right to health’ and European values in health such as equity, universality and access; innovation stimuli which take into account the special characteristics of health technologies and products, such as long lead times, high intensity of investments, high attrition rates, and the lack market incentives for investing in medicines for poor populations; previous experience has shown the gains to be achieved from global, collaborative health research and that some innovations can only occur on a regional/international level; the large and complex character of many global health challenges makes them particularly suited to a ‘grand challenges’ approach to developing global health, which involves cross-sectoral research conducted by multinational consortia within and beyond the EU.’
The Global Health Programme was commissioned by the Swiss government to research platforms on NCDs and related collaborative platforms in order for them to advise the WHO on establishing an NCD monitoring platform for data, good practices and voluntary commitments. This project was asked to consider some specific quetsions. In order to answer these questions, the process included: research on policy documents surrounding the NCD Political Declaration; research on current academic articles on the NCDs debate; speaking to ‘key informants’ from networks related to NCDs and monitoring initiative (NCD Alliance, Health Metrics Network, PePsico/IFBA); Internet/document researchon selected platforms and their monitoring mechanisms, along with any evaluation or advice on ‘lessons learnt’ from the platforms.
The Global Health Programme has contributed to the larger project on Global Governance coordinated by the Lee Kuan Yew School of Public Policy at the National University of Singapore by conducting a research study mapping the contemporary influence of Asian actors in negotiations of Global Health Governance (GHG). The objectives of this research study are reviewing the representation of Asian actors in contemporary literature, identifying the role of Asian actors within selected key institutions involved in global health governance agenda-setting, and analysing the policies and influences of Asian nation-states on global health. This qualitative research project will be based on a review of institutional publications as well as interviews with relevant health attachés and representatives of select Geneva-based organizations involved in global health governance agenda setting (i.e. the World Health Organization, UNAIDS, the Global Fund to Fight AIDS, Tuberculosis, and Malaria; the World Economic Forum; World Trade Organization TRIPS Council; GAVI Alliance). S.T. Lee Project on Global Governance